RU-2861512-C1 - METHOD FOR COMPLEX PHYTOTHERAPEUTIC SUPPORT OF INFLAMMATORY DISEASES OF ORAL MUCOSA

RU2861512C1RU 2861512 C1RU2861512 C1RU 2861512C1RU-2861512-C1

Abstract

FIELD: medicine; therapeutic dentistry. SUBSTANCE: invention can be used in the complex phytotherapeutic support of inflammatory diseases of the oral mucosa. The method involves the use of hydrolate solutions from essential oil plants for therapy, including preliminary performance of aroma procedures, performance of phytotherapy by local action on the oral mucosa in risk zones or areas of inflammation of the oral mucosa, as well as complex diagnostics by conducting a clinical and subjective assessment of the dynamics of the inflammatory process based on a comparative analysis of the results obtained before and after therapy. After initial diagnosis, an aroma procedure is performed by means of relaxation-respiratory aromatherapeutic exposure for 5 minutes to the vapours of a hydrolate from an essential oil plant selected from lavender, rose, cornflower, pine and lemon balm. Then phytotherapy is performed by applying for 5 minutes to the oral mucosa in risk zones or areas of inflammation a hygroscopic absorbent material impregnated with a hydrolate from an essential oil plant selected from laurel, sage, eucalyptus, rosemary and chamomile, or by rinsing the mouth, or by performing irrigation treatment of the gingival margin from a syringe using a cannula, or by spraying onto the gum surface. The course of therapy includes from 1 to 5 procedures. The effectiveness of the therapy is assessed based on the results of repeated complex diagnostics. During complex diagnostics, the clinical assessment of the inflammatory process before and after therapy is carried out by determining the papillary-marginal-alveolar index (PMA) and/or analysing the condition of the oral mucosa using a piezoresonance sensory device, and the subjective assessment is obtained based on the results of the patient filling out the visual analogue scale 'Anxiety level' and the scale 'Determination of oral discomfort'. EFFECT: possibility of achieving a reduction in the severity of clinical signs of inflammation due to the effectiveness of complex phytotherapy of the oral mucosa along with aroma procedures, objectification of the inflammatory state of the mucous membrane, high tolerability and safety of the procedures, ensuring an increase in patient adherence to treatment. 4 cl, 3 dwg, 6 ex

Inventors

RYZHOVA IRINA PETROVNA
Pogosian Natella Mkrtichevna
Novozhilova Mariia Sergeevna
Frolov Aleksei Mikhailovich
Borozentseva Vita Alekseevna
Chikareva Elizaveta Kirilovna
Reznikova Kseniia Viktorovna
Mosina Valeriia Borisovna

Dates

Publication Date: 20260505
Application Date: 20250827

Claims (4)

1. A method for the comprehensive phytotherapeutic management of inflammatory diseases of the oral mucosa, characterized by the use of solutions of hydrolates from essential oil plants for therapy, including preliminary aromatherapy procedures, phytotherapy by local action on the oral mucosa in areas of risk or inflammation of the oral mucosa, as well as comprehensive diagnostics by conducting a clinical and subjective assessment of the dynamics of the inflammatory process based on a comparative analysis of the results obtained before and after therapy, wherein after the initial diagnosis, an aromatherapy procedure is carried out by means of a relaxation-respiratory aromatherapeutic effect for 5 minutes with vapors of a hydrolate from an essential oil plant selected from lavender, rose, cornflower, pine and lemon balm, then phytotherapy is carried out by applying for 5 minutes to the oral mucosa in areas of risk or inflammation a hygroscopic absorbent material impregnated with a hydrolate from an essential oil plant selected from laurel, sage, eucalyptus, rosemary and chamomile, or by rinsing the mouth, or by irrigating the gingival margin with a syringe using a cannula, or by spraying onto the gum surface, while the course of therapy includes from 1 to 5 procedures, the effectiveness of the therapy is assessed based on the results of repeated comprehensive diagnostics, and when conducting a comprehensive diagnosis, a clinical assessment of the inflammatory process before and after therapy is carried out by determining the papillary-marginal-alveolar index (PMA) and / or analyzing the condition of the oral mucosa using a piezoresonance sensor device, and a subjective assessment is obtained based on the results of the patient filling out the visual analogue scale "Level of anxiety" and the scale "Determination of discomfort in the oral cavity".
2. The method according to paragraph 1, characterized in that the subjective assessment is obtained based on the results of the patient filling out a 5-point visual analogue scale "Anxiety Level", where the patient evaluates as follows: 0 points - absolute calm, confidence; relaxation, 1 point - slight alertness, without obvious anxiety; 2 points - slight excitement or anticipation; 3 points - moderate anxiety, worry, tense anticipation; 4 points - obvious emotional tension, worry, discomfort; 5 points - high anxiety, internal tension, fear, panic.
3. The method according to claim 1, characterized in that the subjective assessment is obtained based on the results of the patient filling out a 5-point scale "Determination of discomfort in the oral cavity", where the patient evaluates as follows: 0 points - complete absence of unpleasant sensations, comfort; 1 point - barely noticeable dryness, tension or unusual sensation; 2 points - mild dryness, slight burning or tickling; 3 points - moderate discomfort: pronounced dryness, unpleasant taste; 4 points - obvious discomfort: burning sensation, irritation, viscosity; 5 points - severe discomfort: pain, pronounced burning, unbearable dryness.
4. The method according to paragraph 1, characterized in that the aromatherapy procedures are carried out by diaphragmatic breathing using an aroma diffuser or a personal inhaler.

Description

The invention relates to the field of integrative medicine, namely to preventive and therapeutic dentistry, and can be used for comprehensive patient care in the presence of chronic and latent inflammatory conditions of the oral mucosa, as well as within the framework of adaptive, restorative and psycho-emotional protocols. In modern dental practice, traditional methods of assessing inflammation are actively used: visual examination, determination of the papillary-marginal-alveolar index (hereinafter, the PMA index), determination of the general periodontal index (CPI), Schiller-Pisarev tests to determine the intensity of gum inflammation, etc. For example, the PMA index is a metric developed to determine the prevalence and severity of gingivitis. It stands for Papillary (inflammation of the interdental papillae), Marginal (inflammation of the marginal gingiva), and Attached (inflammation of the attached gingiva). This method is used during clinical dental examinations, periodontal tissue diagnostics, and treatment of inflammatory processes. It allows for assessing the severity of the clinical condition and determining the optimal treatment method. It is a method for determining the effectiveness of the prescribed treatment. The doctor applies an iodine solution to the gums. The intensity and extent of the inflammatory process is determined based on the reaction to the irritant. Inflammatory reactions in individual areas of the gums are taken into account. The entire series is analyzed. The formula is calculated taking into account the person's age and the number of teeth. Points are distributed as follows: • 0 points – if there is no inflammatory process; • 1 point – presence of inflammation of the papilla; • 2 points – presence of inflammation of the papilla and the edge of the gum; • 3 points – presence of inflammation of the marginal and alveolar gums. The calculation of the RMA index is as follows: the sum of the indicators in points / 3 x n x 100%, where n is the number of teeth. Evaluation criteria: • 30% and below indicates mild gingivitis; • From 30% to 60% - about average; • From 60% and above – severe degree. (Internet link: https://irkgmu.ru/src/downloads/b1e142c4_indeksnaya_otsenka_kariesa_i_zabolevaniiy_parodonta.pdf) Electronic odor diagnostic methods and devices (electronic noses) are known, but their use in dentistry, especially in combination with natural therapies, remains extremely limited. However, solutions involving the use of electronic sensors for oral health analysis, as well as developments in inflammation prevention using natural ingredients, are known. Patent RU 2826091 C1, application No. 2024100871, published September 3, 2024, "A Method for Predicting Caries Development Based on the Results of Analyzing the Acid Metabolism Products of Dental Plaque Microflora" is known. The invention describes the use of a portable electronic nose (MAG-8) with replaceable piezoelectric sensors, which analyzes the products of dental plaque metabolism. Biomaterial analysis is performed using a device - a portable electronic nose "MAG-8" with replaceable gas piezoelectric sensors of the OAB type with three different sorbents. In this case, phases weighing 2-4 μg of carboxylated carbon nanotubes for calculating S1, zirconyl nitrate for calculating S2, and hydroxyapatite for calculating S3 are separately applied as piezoelectric sensor sorbents. To bring the piezoelectric sensors into operating mode, the device is warmed up for 20 minutes. Then the swab is placed in the detection cell with sensors no later than 3 minutes after the sample collection and the measurements are started by activating the software of the device, which is combined with a computer. The signal of each individual piezoelectric sensor is recorded in one-second increments. The areas under the output curves of each sensor, respectively, S1, S2, S3, are recorded in the software and the areas under the output curves of each sensor, respectively, S1, S2, S3, are measured. The quotient of the output areas is determined using the formula k = S1 / S2 / S3. In this case, if the k value is less than or equal to 0.30, the sample is determined as having been collected with an error and it is recommended to repeat the study; if the k value is greater than 0.30 and less than 1.5, the sample is determined as the absence of carious processes; if the k value is greater than or equal to 1.5 and less than 2.5, the sample is determined as having a high probability of caries development; if the k value is greater than or equal to 2.5, the sample is determined as the presence of a carious process. The data obtained allows us to predict the risk of dental caries. A drawback is that the solution is focused solely on diagnosing dental caries and does not include the diagnosis and treatment of inflammatory conditions of the oral mucosa. Patent RU 2748338 (published May 24, 2021) proposes a method for reducing inflammation and preventing oxidative stre